S. Nagai et al., GROWTH-INHIBITION OF HUMAN GASTROINTESTINAL CANCER XENOGRAFT LINES BYTREATMENT WITH CPT-11 AND VP-16, Journal of surgical oncology, 54(4), 1993, pp. 211-215
A water-soluble and stable camptothecin derivative, CPT-11, was found
to possess a strong antitumor activity against various murine tumors.
In the present study, CPT-11 was tested against ten human gastrointest
inal cancer xenograft lines carried by nude mice. CPT-11 was very effe
ctive against nine xenograft lines, with the exception of one xenograf
t. On the other hand, VP-16 was ineffective against all these xenograf
t lines. Therefore, CPT-11 is expected to be clinically more effective
against gastrointestinal cancer than the topo II targeting agent. (C)
1993 Wiley-Liss, Inc.